MedWatch

Hedegaard: “We are in talks with the Americans at the moment”

For the second quarter running Bavarian Nordic has raised expectations for the year. The CEO signals continued improvements and remains hopeful about a contract with the US government.

Foto: PR, Bavarian Nordic

“It is a good, solid result. We are capable of raising expectations once again. It is primarily driven by the success we see in our production and delivery of the small pox vaccine.”

Anders Hedegaard, CEO of Bavarian Nordic, talks to Medwatch about the company’s Q3 financial statement, which resulted in a greater turnover than expected and raised expectations for the year.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier